ATLASSunshine Biopharma (SBFM) earnings date: Nov 12, 2026
Sunshine Biopharma (SBFM) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 12, 2026.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on SBFM
| Last price | $2.76 (-6.0%) |
|---|---|
| Normal 1-day range (±1σ) | ±10.5% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Sunshine Biopharma stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Sunshine Biopharma reports on Nov 12, 2026. One email the day before, with ATLAS’s read on Sunshine Biopharma. You can switch it off at any time.
Alert me before SBFM reportsFree to start. Creating an account takes under a minute.
Notify me when Sunshine Biopharma reports
Track SBFM free Add Sunshine Biopharma to a free ATLAS watchlist and see its next report date in one place.
SBFM earnings at a glance
| Next report (confirmed) | Thu, Nov 12, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| Last report | Aug 13, 2026 · Beat |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | -22.1% |
| Average move around a report | ±12.8% (last 5) |
| Sector | Healthcare · Drug Manufacturers - Specialty & Generic |
Sunshine Biopharma earnings history: last 5 reports
Sunshine Biopharma last reported on Aug 13, 2026: EPS of -$23.00 against an estimate of -$24.00 (+4.2% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 13, 2026 | -$24.00 | -$23.00 | +4.2% | Beat | -5.0% |
| May 13, 2026 | -$32.00 | -$50.00 | -56.3% | Miss | -55.3% |
| May 6, 2026 | $2.55 | $2.72 | +6.7% | Beat | +2.9% |
| Apr 3, 2026 | -$54.00 | -$92.00 | -70.4% | Miss | 0.0% |
| Jan 15, 2026 | $2.98 | $3.14 | +5.4% | Beat | -0.8% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for SBFM
See the fair value, the probability range and the earnings history of Sunshine Biopharma on its ATLAS page.
Sunshine Biopharma (SBFM) stock analysisPlans from €3.99 a month.
Sunshine Biopharma earnings: frequently asked questions
When does Sunshine Biopharma (SBFM) report earnings?
Sunshine Biopharma is scheduled to report on Thursday, November 12, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
How often does SBFM beat earnings estimates?
Of its last 5 reports with a recorded result, Sunshine Biopharma beat the EPS estimate 3 times; the average surprise was -22.1%. Past results do not predict the next one.
How much does SBFM move around earnings?
Over its last 5 reports the stock moved an average of 12.8% (absolute, from the close before the report day to the close after it), and finished higher 1 of 5 times.
Did Sunshine Biopharma beat earnings estimates last quarter?
Sunshine Biopharma last reported on Aug 13, 2026: EPS of -$23.00 against an estimate of -$24.00 (+4.2% surprise), a beat.
How much does SBFM usually move in a day?
On a normal trading day the ATLAS model puts SBFM’s one-day range at about ±10.5%, with a 47% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 12, 2026
Educational information, not investment advice. Disclaimer